Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer

BACKGROUND: Sagopilone is the first fully synthetic epothilone in clinical development and has demonstrated promising preclinical activity. This phase I/II, prospective, open-label trial investigated the efficacy and safety of sagopilone plus carboplatin in patients with recurrent platinum-sensitive...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: McMeekin, S, Patel, R, Verschraegen, C, Celano, P, Burke, J, Plaxe, S, Ghatage, P, Giurescu, M, Stredder, C, Wang, Y, Schmelter, T
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2012
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251849/
https://ncbi.nlm.nih.gov/pubmed/22108514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.499
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia